| |
|
|
|
Kaleido Biosciences Inc  
|
|
9.84 0.08 (0.01%) |
02-24 16:00 |
|
Open: |
10.01 |
Pre close: |
9.76 |
Target:
|
18.84
|
|
High: |
10.3 |
Low: |
9.59 |
Resistance:
|
16.13
20.50
|
|
Volume: |
170,381 |
Market Cap: |
412M |
Support:
|
9.05
7.53
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.25
 |
MACD |
MACD(12,26):
|
-0.42 |
|
MA(20): |
11.96 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
9.56 |
Stochastic Oscillator |
%K(14,3):
|
12.76  |
|
MA(250): |
7.81 |
%D(3): |
8.69 |
|
Average Volume(K) |
3-Month: |
24900
|
52-Week |
High:
|
20.50 |
|
10-Days: |
31151 |
Low: |
2.82 |
|
RSI |
RSI(14):
|
40.25 |
Change(%): |
62.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.540 |
Return on Equity (ttm) |
-159.1 |
Shares Out. (M) |
35.55 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-59.7 |
Shares Float (M) |
10.99 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.03 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
79.77 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
3360 |
|
Book Value (p.s.) |
1.000 |
EBITDA (p.s.) |
-2.164 |
P/E |
-3.87 |
|
Sales Per Share |
0.021 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.84 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-65.87 |
P/S |
477.89 |
|
Operating Margin |
-10730.19 |
Levered Free Cash Flow
(M) |
-44.05 |
P/CF |
-5.31 |
|
|
|
|
|
|
